DRAK2 Participates in a Negative Feedback Loop to Control TGF-β/Smads Signaling by Binding to Type I TGF-β Receptor

Cell Reports

Volumn 2, Issue 5, 2012, Pages 1286-1299

  Yang, Kyung Min ^a   Kim, Wonjoo ^a   Bae, Eunjin ^a   Gim, Jungsoo ^b   Weist, Brian M ^c   Jung, Yunshin ^a   Hyun, Ja Shil ^a   Hernandez, Jennifer B ^c   Leem, Sun Hee ^d   Park, Taesung ^b   Jeong, Joon ^e   Walsh, Craig M ^c   Kim, Seong Jin ^a  

^a CHA University   (South Korea)

^b Seoul National University   (South Korea)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Dong A University   (South Korea)

^e Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

DAP KINASE RELATED APOPTOSIS INDUCING PROTEIN KINASE 2; EPIDERMAL GROWTH FACTOR RECEPTOR 2; REGULATOR PROTEIN; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER CELL; CARCINOGENICITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; MOUSE; NEGATIVE FEEDBACK; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMALS; APOPTOSIS REGULATORY PROTEINS; BONE MORPHOGENETIC PROTEINS; BREAST NEOPLASMS; CELL LINE, TUMOR; FEMALE; HEK293 CELLS; HELA CELLS; HUMANS; MICE; MICE, SCID; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SMAD PROTEINS; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TRANSPLANTATION, HETEROLOGOUS; TUMOR SUPPRESSOR PROTEINS;

EID: 84870473950     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2012.09.028     Document Type: Article

References (28)

1. Bialik S., Kimchi A. The death-associated protein kinases: structure, function, and beyond. Annu. Rev. Biochem. 2006, 75:189-210.
2. Bos P.D., Zhang X.H., Nadal C., Shu W., Gomis R.R., Nguyen D.X., Minn A.J., van de Vijver M.J., Gerald W.L., Foekens J.A., Massagué J. Genes that mediate breast cancer metastasis to the brain. Nature 2009, 459:1005-1009.
3. Chang J., Park K., Bang Y.J., Kim W.S., Kim D., Kim S.J. Expression of transforming growth factor β type II receptor reduces tumorigenicity in human gastric cancer cells. Cancer Res. 1997, 57:2856-2859.
4. Ebisawa T., Fukuchi M., Murakami G., Chiba T., Tanaka K., Imamura T., Miyazono K. Smurf1 interacts with transforming growth factor-β type I receptor through Smad7 and induces receptor degradation. J. Biol. Chem. 2001, 276:12477-12480.
5. Feng X.H., Derynck R. Specificity and versatility in tgf-β signaling through Smads. Annu. Rev. Cell Dev. Biol. 2005, 21:659-693.
6. Friedrich M.L., Cui M., Hernandez J.B., Weist B.M., Andersen H.M., Zhang X., Huang L., Walsh C.M. Modulation of DRAK2 autophosphorylation by antigen receptor signaling in primary lymphocytes. J. Biol. Chem. 2007, 282:4573-4584.
7. Han S.U., Kim H.T., Seong D.H., Kim Y.S., Park Y.S., Bang Y.J., Yang H.K., Kim S.J. Loss of the Smad3 expression increases susceptibility to tumorigenicity in human gastric cancer. Oncogene 2004, 23:1333-1341.
8. Hartmann T.B., Mattern E., Wiedemann N., van Doorn R., Willemze R., Niikura T., Hildenbrand R., Schadendorf D., Eichmüller S.B. Identification of selectively expressed genes and antigens in CTCL. Exp. Dermatol. 2008, 17:324-334.
9. Hayashi H., Abdollah S., Qiu Y., Cai J., Xu Y.Y., Grinnell B.W., Richardson M.A., Topper J.N., Gimbrone M.A., Wrana J.L., Falb D. The MAD-related protein Smad7 associates with the TGFbeta receptor and functions as an antagonist of TGFbeta signaling. Cell 1997, 89:1165-1173.
10. Itoh S., ten Dijke P. Negative regulation of TGF-β receptor/Smad signal transduction. Curr. Opin. Cell Biol. 2007, 19:176-184.
11. Kavsak P., Rasmussen R.K., Causing C.G., Bonni S., Zhu H., Thomsen G.H., Wrana J.L. Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF β receptor for degradation. Mol. Cell 2000, 6:1365-1375.
12. Kohn E.A., Du Z., Sato M., Van Schyndle C.M., Welsh M.A., Yang Y.A., Stuelten C.H., Tang B., Ju W., Bottinger E.P., Wakefield L.M. A novel approach for the generation of genetically modified mammary epithelial cell cultures yields new insights into TGF-β signaling in the mammary gland. Breast Cancer Res. 2010, 12:R83.
13. Köqel D., Prehn J.H., Scheidtmann K.H. The DAP kinase family of pro-apoptotic proteins: novel players in the apoptotic game. Bioessays 2001, 23:325-358.
14. Kuwahara H.N., Nakamura N., Kanazawa H. Nuclear localization of the serine/threonine kinase DRAK2 is involved in UV-induced apoptosis. Biol. Pharm. Bull. 2006, 29:225-233.
15. Mao J., Qiao X., Luo H., Wu J. Transgenic drak2 overexpression in mice leads to increased T cell apoptosis and compromised memory T cell development. J. Biol. Chem. 2006, 281:12587-12595.
16. Mao J., Luo H., Han B., Bertrand R., Wu J. Drak2 is upstream of p70S6 kinase: its implication in cytokine-induced islet apoptosis, diabetes, and islet transplantation. J. Immunol. 2009, 182:4762-4770.
17. Massagué J. TGFbeta in Cancer. Cell 2008, 134:215-230.
18. Massagué J., Blain S.W., Lo R.S. TGFbeta signaling in growth control, cancer, and heritable disorders. Cell 2000, 103:295-309.
19. Massagué J., Seoane J., Wotton D. Smad transcription factors. Genes Dev. 2005, 19:2783-2810.
20. McGargill M.A., Wen B.G., Walsh C.M., Hedrick S.M. A deficiency in Drak2 results in a T cell hypersensitivity and an unexpected resistance to autoimmunity. Immunity 2004, 21:781-791.
21. Ramos S.J., Hernandez J.B., Gatzka M., Walsh C.M. Enhanced T cell apoptosis within Drak2-deficient mice promotes resistance to autoimmunity. J. Immunol. 2008, 181:7606-7616.
22. Sanjo H., Kawai T., Akira S. DRAKs, novel serine/threonine kinases related to death-associated protein kinase that trigger apoptosis. J. Biol. Chem. 1998, 273:29066-29071.
23. Shi Y., Massagué J. Mechanisms of TGF-β signaling from cell membrane to the nucleus. Cell 2003, 113:685-700.
24. Tusher V.G., Tibshirani R., Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. USA 2001, 98:5116-5121.
25. Wang Y., Klijn J.G., Zhang Y., Sieuwerts A.M., Look M.P., Yang F., Talantov D., Timmermans M., Meijer-van Gelder M.E., Yu J., et al. Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 2005, 365:671-679.
26. Watanabe Y., Itoh S., Goto T., Ohnishi E., Inamitsu M., Itoh F., Satoh K., Wiercinska E., Yang W., Shi L., et al. TMEPAI, a transmembrane TGF-β-inducible protein, sequesters Smad proteins from active participation in TGF-β signaling. Mol. Cell 2010, 37:123-134.
27. Yan X., Liu Z., Chen Y. Regulation of TGF-β signaling by Smad7. Acta Biochim. Biophys. Sin. (Shanghai) 2009, 41:263-272.
28. Yu L., Hébert M.C., Zhang Y.E. TGF-β receptor-activated p38 MAP kinase mediates Smad-independent TGF-β responses. EMBO J. 2002, 21:3749-3759.